About the journal
The leading peer-reviewed journal on multiple sclerosis — pathogenesis, disease-modifying therapy, neurorehabilitation, and outcomes research. Founded under Edward Arnold in 1995 and transferred to SAGE in 2006, where it continues as Multiple Sclerosis Journal.
Scope
- MS pathogenesis and neuroimmunology
- disease-modifying therapies
- neurorehabilitation in MS
- MS epidemiology and outcomes